Glucuronomannan GM2 from <i>Saccharina japonica</i> Enhanced Mitochondrial Function and Autophagy in a Parkinson’s Model
Parkinson’s disease (PD), one of the most common neurodegenerative disorders, is caused by dopamine depletion in the striatum and dopaminergic neuron degeneration in the substantia nigra. In our previous study, we hydrolyzed the fucoidan from <i>Saccharina japonica</i>, obtaining three g...
Main Authors: | Yingjuan Liu, Weihua Jin, Zhenzhen Deng, Quanbin Zhang, Jing Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Marine Drugs |
Subjects: | |
Online Access: | https://www.mdpi.com/1660-3397/19/2/58 |
Similar Items
-
Preparation and Neuroprotective Activity of Glucuronomannan Oligosaccharides in an MPTP-Induced Parkinson’s Model
by: Yingjuan Liu, et al.
Published: (2020-08-01) -
Structural Features of Sulfated Glucuronomannan Oligosaccharides and Their Antioxidant Activity
by: Weihua Jin, et al.
Published: (2018-08-01) -
Synergistic Effect of Mitochondrial and Lysosomal Dysfunction in Parkinson’s Disease
by: Flora Guerra, et al.
Published: (2019-05-01) -
Correlation between mitochondrial dysfunction and the pathogenesis of Parkinson's disease
by: Xiao-yu LIU, et al.
Published: (2014-02-01) -
O-GlcNAc regulation of autophagy and α-synuclein homeostasis; implications for Parkinson’s disease
by: Willayat Y. Wani, et al.
Published: (2017-07-01)